Chicago Equity Partners LLC increased its position in Varian Medical Systems, Inc. (NYSE:VAR) by 14.5% during the third quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 33,770 shares of the medical equipment provider’s stock after purchasing an additional 4,275 shares during the quarter. Chicago Equity Partners LLC’s holdings in Varian Medical Systems were worth $3,379,000 as of its most recent SEC filing.

Other hedge funds have also recently modified their holdings of the company. Manchester Capital Management LLC grew its stake in Varian Medical Systems by 16.5% in the 2nd quarter. Manchester Capital Management LLC now owns 1,057 shares of the medical equipment provider’s stock valued at $109,000 after buying an additional 150 shares during the last quarter. Parallel Advisors LLC grew its stake in Varian Medical Systems by 10.1% in the 2nd quarter. Parallel Advisors LLC now owns 1,357 shares of the medical equipment provider’s stock valued at $132,000 after buying an additional 125 shares during the last quarter. Penserra Capital Management LLC grew its stake in Varian Medical Systems by 13.0% in the 2nd quarter. Penserra Capital Management LLC now owns 1,820 shares of the medical equipment provider’s stock valued at $187,000 after buying an additional 210 shares during the last quarter. Northwestern Mutual Wealth Management Co. grew its stake in Varian Medical Systems by 0.6% in the 2nd quarter. Northwestern Mutual Wealth Management Co. now owns 1,912 shares of the medical equipment provider’s stock valued at $197,000 after buying an additional 11 shares during the last quarter. Finally, Pacer Advisors Inc. grew its stake in Varian Medical Systems by 8.0% in the 2nd quarter. Pacer Advisors Inc. now owns 1,960 shares of the medical equipment provider’s stock valued at $202,000 after buying an additional 145 shares during the last quarter. 99.81% of the stock is currently owned by institutional investors.

In related news, EVP Kolleen T. Kennedy sold 1,088 shares of the stock in a transaction that occurred on Monday, August 14th. The shares were sold at an average price of $97.91, for a total transaction of $106,526.08. Following the sale, the executive vice president now owns 26,600 shares in the company, valued at approximately $2,604,406. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director R Andrew Eckert sold 5,651 shares of the stock in a transaction that occurred on Friday, October 6th. The stock was sold at an average price of $102.39, for a total transaction of $578,605.89. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 41,828 shares of company stock worth $4,337,416. Company insiders own 0.91% of the company’s stock.

ILLEGAL ACTIVITY WARNING: This article was first posted by The Cerbat Gem and is owned by of The Cerbat Gem. If you are accessing this article on another website, it was illegally stolen and reposted in violation of United States and international copyright and trademark law. The correct version of this article can be accessed at https://www.thecerbatgem.com/2017/11/11/varian-medical-systems-inc-var-shares-bought-by-chicago-equity-partners-llc.html.

Varian Medical Systems, Inc. (NYSE:VAR) opened at $107.55 on Friday. Varian Medical Systems, Inc. has a 52-week low of $75.54 and a 52-week high of $108.78. The stock has a market cap of $9,886.04, a P/E ratio of 28.57, a price-to-earnings-growth ratio of 3.16 and a beta of 0.65. The company has a current ratio of 1.41, a quick ratio of 1.13 and a debt-to-equity ratio of 0.18.

Varian Medical Systems (NYSE:VAR) last announced its earnings results on Wednesday, October 25th. The medical equipment provider reported $1.09 earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of $1.19 by ($0.10). Varian Medical Systems had a return on equity of 23.68% and a net margin of 8.85%. The business had revenue of $739.00 million for the quarter, compared to analyst estimates of $741.69 million. During the same quarter in the previous year, the company earned $1.03 EPS. The business’s revenue for the quarter was down 1.1% on a year-over-year basis. sell-side analysts expect that Varian Medical Systems, Inc. will post 4.26 earnings per share for the current year.

A number of research analysts recently commented on the stock. BTIG Research lowered shares of Varian Medical Systems from a “buy” rating to a “neutral” rating in a research note on Thursday, September 7th. They noted that the move was a valuation call. Citigroup Inc. upped their price target on shares of Varian Medical Systems from $119.00 to $121.00 and gave the company a “neutral” rating in a research note on Monday, October 30th. Royal Bank Of Canada reiterated a “hold” rating and issued a $100.00 price target on shares of Varian Medical Systems in a research note on Friday, September 1st. Robert W. Baird reiterated a “neutral” rating and issued a $99.00 price target (up previously from $89.00) on shares of Varian Medical Systems in a research note on Friday, July 14th. Finally, BidaskClub lowered shares of Varian Medical Systems from a “strong-buy” rating to a “buy” rating in a research note on Monday, July 24th. Three research analysts have rated the stock with a sell rating, eight have assigned a hold rating and one has given a buy rating to the company. The company currently has an average rating of “Hold” and a consensus target price of $97.83.

Varian Medical Systems Company Profile

Varian Medical Systems, Inc is a manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy and brachytherapy medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy and brachytherapy.

Institutional Ownership by Quarter for Varian Medical Systems (NYSE:VAR)

Receive News & Stock Ratings for Varian Medical Systems Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Varian Medical Systems Inc. and related stocks with our FREE daily email newsletter.